Longboard pharmaceuticals to present at three upcoming investor conferences in november

La jolla, calif.--(business wire)---- $lbph #epilepsy--longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior management team will present at three upcoming investor conferences in november. conference details: event: guggenheim healthcare talks 5th annual inflammation, neurology & immunology (ini) conference details: presenting in a fireside chat forma.
LBPH Ratings Summary
LBPH Quant Ranking